Bio-Techne Corp (TECH)
75.01
+1.58
(+2.15%)
USD |
NASDAQ |
May 02, 11:40
Bio-Techne Cash from Investing (Quarterly): -23.67M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.67M |
| September 30, 2023 | -154.11M |
| June 30, 2023 | -4.756M |
| March 31, 2023 | -241.10M |
| December 31, 2022 | -0.109M |
| September 30, 2022 | -19.69M |
| June 30, 2022 | -18.57M |
| March 31, 2022 | -35.99M |
| December 31, 2021 | -35.17M |
| September 30, 2021 | -7.12M |
| June 30, 2021 | -226.90M |
| March 31, 2021 | 0.129M |
| December 31, 2020 | -8.604M |
| September 30, 2020 | -8.138M |
| June 30, 2020 | -10.47M |
| March 31, 2020 | 19.36M |
| December 31, 2019 | 33.30M |
| September 30, 2019 | -15.08M |
| June 30, 2019 | -30.32M |
| March 31, 2019 | -4.736M |
| December 31, 2018 | -13.63M |
| September 30, 2018 | -288.11M |
| June 30, 2018 | 37.97M |
| March 31, 2018 | -57.93M |
| December 31, 2017 | -6.345M |
| Date | Value |
|---|---|
| September 30, 2017 | -12.40M |
| June 30, 2017 | -4.701M |
| March 31, 2017 | 0.004M |
| December 31, 2016 | -38.79M |
| September 30, 2016 | -262.47M |
| June 30, 2016 | -3.618M |
| March 31, 2016 | -13.99M |
| December 31, 2015 | -4.805M |
| September 30, 2015 | -85.16M |
| June 30, 2015 | -5.521M |
| March 31, 2015 | -3.148M |
| December 31, 2014 | -63.07M |
| September 30, 2014 | -354.75M |
| June 30, 2014 | 163.68M |
| March 31, 2014 | -0.081M |
| December 31, 2013 | -8.783M |
| September 30, 2013 | -105.13M |
| June 30, 2013 | -4.759M |
| March 31, 2013 | -11.52M |
| December 31, 2012 | -9.00M |
| September 30, 2012 | -5.92M |
| June 30, 2012 | -2.534M |
| March 31, 2012 | -7.856M |
| December 31, 2011 | -0.829M |
| September 30, 2011 | -10.45M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-241.10M
Minimum
Mar 2023
33.30M
Maximum
Dec 2019
-41.42M
Average
-15.08M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies Inc | -95.00M |
| Bio-Rad Laboratories Inc | 72.20M |
| Revvity Inc | -18.18M |
| Twist Bioscience Corp | 4.165M |
| AIM ImmunoTech Inc | -0.214M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 83.12M |
| Cash from Financing (Quarterly) | -81.40M |
| Free Cash Flow | 225.39M |
| Free Cash Flow Per Share (Quarterly) | 0.4264 |
| Free Cash Flow to Equity (Quarterly) | 61.25M |
| Free Cash Flow to Firm (Quarterly) | 71.14M |
| Free Cash Flow Yield | 1.86% |